Retinal Venous Pressure (RVP) in Normals
This study is currently recruiting participants.
Verified January 2013 by University Hospital, Basel, Switzerland
Sponsor:
University Hospital, Basel, Switzerland
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01732042
First received: October 24, 2012
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Determinate the standard values of the retinal venous pressure in a cohort of healthy subjects.
| Condition |
|---|
|
Healthy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Retinal Venous Pressure (RVP) in Normals |
Further study details as provided by University Hospital, Basel, Switzerland:
Primary Outcome Measures:
- Retinal venous pressure [ Time Frame: 1 hour ] [ Designated as safety issue: No ]Quantification of the retinal venous pressure as a standard value in a cohort of healthy volunteers
| Estimated Enrollment: | 200 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |
The retinal venous pressure (RVP) is an increasingly important dimension in the clinical assessment of retinal blood flow.
In literature only very few and also divergent data on the retinal venous pressure in healthy volunteers are described. A normal value study will provide us with an up-to-date database.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
healthy volunteers
Criteria
Inclusion Criteria:
- healthy
Exclusion Criteria:
- eye diseases
- systemic diseases
- term medication (except contraceptives)
- pregnancy
- allergies to the ingredients Alcaine, Tropicamide and Phenylephrine
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01732042
Contacts
| Contact: Michael Baertschi, MSc Optom | +41 61 2658809 | mbaertschi@uhbs.ch |
| Contact: Maneli Mozaffarieh, MD | +41 61 265 8807 | mmozaffarieh@uhbs.ch |
Locations
| Switzerland | |
| University of Basel, Dept. of Ophthalmology | Recruiting |
| Basel, Switzerland, 4031 | |
| Contact: Michael Baertschi, MSc Optom +41 61 2658809 mbaertschi@uhbs.ch | |
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
| Study Director: | Josef Flammer, MD | University of Basel, Dept. of Ophthalmology |
More Information
No publications provided
| Responsible Party: | University Hospital, Basel, Switzerland |
| ClinicalTrials.gov Identifier: | NCT01732042 History of Changes |
| Other Study ID Numbers: | USB-2011-326 |
| Study First Received: | October 24, 2012 |
| Last Updated: | January 16, 2013 |
| Health Authority: | Switzerland: Swissmedic |
Keywords provided by University Hospital, Basel, Switzerland:
|
retinal venous pressure |
ClinicalTrials.gov processed this record on May 23, 2013